Gritstone Bio Analyst Ratings
Gritstone Bio Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/10/2023 | 300% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 05/15/2023 | 300% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 03/28/2023 | 357.14% | B. Riley Securities | → $8 | Initiates Coverage On | → Buy |
| 03/14/2023 | 300% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/15/2023 | 300% | HC Wainwright & Co. | → $7 | Maintains | Buy |
| 11/07/2022 | 300% | HC Wainwright & Co. | $12 → $7 | Maintains | Buy |
| 10/31/2022 | 242.86% | Piper Sandler | → $6 | Initiates Coverage On | → Overweight |
| 08/22/2022 | 14.29% | Goldman Sachs | → $2 | Downgrades | Neutral → Sell |
| 05/09/2022 | 585.71% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
| 03/14/2022 | 757.14% | HC Wainwright & Co. | $24 → $15 | Maintains | Buy |
| 01/20/2021 | 357.14% | Baird | → $8 | Downgrades | Outperform → Underperform |
| 01/20/2021 | 1271.43% | HC Wainwright & Co. | $16 → $24 | Maintains | Buy |
| 07/14/2020 | 871.43% | BTIG | $31 → $17 | Maintains | Buy |
| 07/26/2019 | 871.43% | Baird | → $17 | Initiates Coverage On | → Outperform |
| 03/15/2019 | 1042.86% | Raymond James | → $20 | Initiates Coverage On | → Outperform |
| 03/07/2019 | 871.43% | HC Wainwright & Co. | → $17 | Initiates Coverage On | → Buy |
| 10/23/2018 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 10/23/2018 | 928.57% | Goldman Sachs | → $18 | Initiates Coverage On | → Neutral |
| 10/23/2018 | 1385.71% | BTIG | → $26 | Initiates Coverage On | → Buy |
| 10/23/2018 | 1328.57% | Barclays | → $25 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/10/2023 | 300% | HC Wainwright & Co. | → 7 美元 | 重申 | 购买 → 购买 |
| 05/15/2023 | 300% | HC Wainwright & Co. | → 7 美元 | 重申 | 购买 → 购买 |
| 03/28/2023 | 357.14% | B. 莱利证券 | → 8 美元 | 启动覆盖开启 | → 购买 |
| 03/14/2023 | 300% | HC Wainwright & Co. | → 7 美元 | 重申 | → 购买 |
| 02/15/2023 | 300% | HC Wainwright & Co. | → 7 美元 | 维护 | 购买 |
| 2022 年 7 月 11 日 | 300% | HC Wainwright & Co. | 12 美元 → 7 美元 | 维护 | 购买 |
| 10/31/2022 | 242.86% | 派珀·桑德勒 | → 6 美元 | 启动覆盖开启 | → 超重 |
| 2022 年 8 月 22 日 | 14.29% | 高盛 | → 2 美元 | 降级 | 中性 → 卖出 |
| 05/09/2022 | 585.71% | HC Wainwright & Co. | 15 美元 → 12 美元 | 维护 | 购买 |
| 03/14/2022 | 757.14% | HC Wainwright & Co. | 24 美元 → 15 美元 | 维护 | 购买 |
| 2021 年 1 月 20 日 | 357.14% | 贝尔德 | → 8 美元 | 降级 | 跑赢大盘 → 表现不佳 |
| 2021 年 1 月 20 日 | 1271.43% | HC Wainwright & Co. | 16 美元 → 24 美元 | 维护 | 购买 |
| 2020 年 7 月 14 日 | 871.43% | BTIG | 31 美元 → 17 美元 | 维护 | 购买 |
| 07/26/2019 | 871.43% | 贝尔德 | → 17 美元 | 启动覆盖开启 | → 跑赢大盘 |
| 03/15/2019 | 1042.86% | 雷蒙德·詹姆 | → 20 美元 | 启动覆盖开启 | → 跑赢大盘 |
| 2019 年 7 月 3 日 | 871.43% | HC Wainwright & Co. | → 17 美元 | 启动覆盖开启 | → 购买 |
| 10/23/2018 | — | Cowen & Co. | 启动覆盖开启 | → 跑赢大盘 | |
| 10/23/2018 | 928.57% | 高盛 | → 18 美元 | 启动覆盖开启 | → 中立 |
| 10/23/2018 | 1385.71% | BTIG | → 26 美元 | 启动覆盖开启 | → 购买 |
| 10/23/2018 | 1328.57% | 巴克莱 | → 25 美元 | 启动覆盖开启 | → 超重 |
What is the target price for Gritstone Bio (GRTS)?
Gritstone Bio（GRTS）的目标价格是多少？
The latest price target for Gritstone Bio (NASDAQ: GRTS) was reported by HC Wainwright & Co. on August 10, 2023. The analyst firm set a price target for $7.00 expecting GRTS to rise to within 12 months (a possible 300.00% upside). 8 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月10日公布了Gritstone Bio（纳斯达克股票代码：GRTS）的最新目标股价。这家分析公司将目标股价定为7.00美元，预计GRTS将在12个月内升至7.00美元（可能上涨300.00％）。去年有8家分析公司公布了评级。
What is the most recent analyst rating for Gritstone Bio (GRTS)?
分析师对Gritstone Bio（GRTS）的最新评级是多少？
The latest analyst rating for Gritstone Bio (NASDAQ: GRTS) was provided by HC Wainwright & Co., and Gritstone Bio reiterated their buy rating.
Gritstone Bio（纳斯达克股票代码：GRTS）的最新分析师评级由HC Wainwright & Co. 提供，Gritstone Bio重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Gritstone Bio (GRTS)?
Gritstone Bio（GRTS）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gritstone Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gritstone Bio was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
分析师在进行了广泛的研究（包括浏览公开财务报表、与Gritstone Bio的高管和客户交谈以及听取财报电话会议）后得出股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Gritstone Bio的最后一次评级是在2023年8月10日提交的，因此您应该预计下一个评级将在2024年8月10日左右公布。
Is the Analyst Rating Gritstone Bio (GRTS) correct?
分析师对 Gritstone Bio (GRTS) 的评级正确吗？
While ratings are subjective and will change, the latest Gritstone Bio (GRTS) rating was a reiterated with a price target of $0.00 to $7.00. The current price Gritstone Bio (GRTS) is trading at is $1.75, which is within the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的Gritstone Bio（GRTS）评级得到了重申，目标股价为0.00美元至7.00美元。Gritstone Bio（GRTS）目前的交易价格为1.75美元，在分析师的预测区间内。